Patel, R.K.; Parappilly, M.; Farley, H.C.; Latour, E.J.; Wang, L.G.; Nair, A.M.; Lu, E.S.; Sims, Z.; Park, B.; Nelson, K.;
et al. Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer. Cancers 2024, 16, 3650.
https://doi.org/10.3390/cancers16213650
AMA Style
Patel RK, Parappilly M, Farley HC, Latour EJ, Wang LG, Nair AM, Lu ES, Sims Z, Park B, Nelson K,
et al. Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer. Cancers. 2024; 16(21):3650.
https://doi.org/10.3390/cancers16213650
Chicago/Turabian Style
Patel, Ranish K., Michael Parappilly, Hannah C. Farley, Emile J. Latour, Lei G. Wang, Ashvin M. Nair, Ethan S. Lu, Zachary Sims, Byung Park, Katherine Nelson,
and et al. 2024. "Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer" Cancers 16, no. 21: 3650.
https://doi.org/10.3390/cancers16213650
APA Style
Patel, R. K., Parappilly, M., Farley, H. C., Latour, E. J., Wang, L. G., Nair, A. M., Lu, E. S., Sims, Z., Park, B., Nelson, K., Mayo, S. C., Mills, G. B., Sheppard, B. C., Chang, Y. H., Gibbs, S. L., Kardosh, A., Lopez, C. D., & Wong, M. H.
(2024). Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer. Cancers, 16(21), 3650.
https://doi.org/10.3390/cancers16213650